• Logo
  • SBMUJournals

Fibroblast-Myofibroblast Crosstalk after Exposure to Mesenchymal Stem Cells Secretome

Khadijeh Jalili Angourani, Sogol Mazhari, Shirin Farivar, Donya Salman Mahini, Abdolreza Rouintan, Kaveh Baghaei
72

Views

PDF

Abstract

.


Keywords

MSCs-secretome; fibroblast; Myofibroblast; TGF-B; ?-SMA; collagen I; collagen III

References

Rockey DC, Bell PD, Hill JAJNEJoM. Fibrosis—a common pathway to organ injury and failure. 2015;372(12):1138-49.

Denton CP, Black CM, Abraham DJJNRR. Mechanisms and consequences of fibrosis in systemic sclerosis. 2006;2(3):134.

Wilson M, Wynn TJMi. Pulmonary fibrosis: pathogenesis, etiology and regulation. 2009;2(2):103.

Liu YJKi. Renal fibrosis: new insights into the pathogenesis and therapeutics. 2006;69(2):213-7.

Wynn TAJTJoci. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. 2007;117(3):524-9.

Borsi L, Castellani P, Risso AM, Leprini A, Zardi LJFl. Transforming growth factor‐β regulates the splicing pattern of fibronectin messenger RNA precursor. 1990;261(1):175-8.

Hinz B, Dugina V, Ballestrem C, Wehrle-Haller B, Chaponnier CJMbotc. α-Smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. 2003;14(6):2508-19.

Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat M-L, Gabbiani GJTAjop. The myofibroblast: one function, multiple origins. 2007;170(6):1807-16.

Vaughan MB, Howard EW, Tomasek JJJEcr. Transforming growth factor-β1 promotes the morphological and functional differentiation of the myofibroblast. 2000;257(1):180-9.

Ohji M, Sundarraj N, Thoft RAJCer. Transforming growth factor-β stimulates collagen and fibronectin synthesis by human corneal stromal fibroblasts in vitro. 1993;12(8):703-9.

Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. 1986;83(12):4167-71.

Meng X-m, Nikolic-Paterson DJ, Lan HYJNRN. TGF-β: the master regulator of fibrosis. 2016;12(6):325.

Desmoulière A, Geinoz A, Gabbiani F, Gabbiani GJTJocb. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. 1993;122(1):103-11.

Ignotz RA, Massague JJJoBC. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. 1986;261(9):4337-45.

Hocevar BA, Howe PH. Analysis of TGFβ-mediated synthesis of extracellular matrix components. Transforming Growth Factor-Beta Protocols: Springer; 2000. p. 55-65.

Border WA, Ruoslahti EJTJoci. Transforming growth factor-beta in disease: the dark side of tissue repair. 1992;90(1):1-7.

Montesano R, Orci LJPotNAoS. Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. 1988;85(13):4894-7.

Usunier B, Benderitter M, Tamarat R, Chapel AJSci. Management of fibrosis: the mesenchymal stromal cells breakthrough. 2014;2014.

Zannettino A, Paton S, Arthur A, Khor F, Itescu S, Gimble J, et al. Multipotential human adipose‐derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. 2008;214(2):413-21.

Jo Y-Y, Lee H-J, Kook S-Y, Choung H-W, Park J-Y, Chung J-H, et al. Isolation and characterization of postnatal stem cells from human dental tissues. 2007;13(4):767-73.

Kim B-C, Bae H, Kwon I-K, Lee E-J, Park J-H, Khademhosseini A, et al. Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their applications to tissue engineering and regenerative medicine. 2012;18(3):235-44.

Oh W, Kim D-S, Yang YS, Lee JKJCi. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. 2008;251(2):116-23.

Hoogduijn M, Crop M, Peeters A, Van Osch G, Balk A, Ijzermans J, et al. Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. 2007;16(4):597-604.

Murray IR, West CC, Hardy WR, James AW, Park TS, Nguyen A, et al. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. 2014;71(8):1353-74.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. 2006;8(4):315-7.

Ullah I, Subbarao RB, Rho GJJBr. Human mesenchymal stem cells-current trends and future prospective. 2015;35(2):e00191.

Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J, Moorman M, et al. Multilineage potential of adult human mesenchymal stem cells. 1999;284(5411):143-7.

Friedenstein A, Chailakhjan R, Lalykina KJCP. The development of fibroblast colonies in monolayer cultures of guinea‐pig bone marrow and spleen cells. 1970;3(4):393-403.

Chen Y, Wang C, Huang Q, Wu D, Cao J, Xu X, et al. Caveolin-1 plays an important role in the differentiation of bone marrow-derived mesenchymal stem cells into cardiomyocytes. 2017;136(1):40-8.

Squillaro T, Peluso G, Galderisi UJCt. Clinical trials with mesenchymal stem cells: an update. 2016;25(5):829-48.

Parekkadan B, Milwid JMJArobe. Mesenchymal stem cells as therapeutics. 2010;12:87-117.

Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, et al. Identification of IL-10 and TGF-β transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. 2006;13(4-5):217-26.

Zhang X, Wang H, Shi Y, Peng W, Zhang S, Zhang W, et al. Role of bone marrow‐derived mesenchymal stem cells in the prevention of hyperoxia‐induced lung injury in newborn mice. 2012;36(6):589-94.

Pereira RF, O’Hara MD, Laptev AV, Halford KW, Pollard MD, Class R, et al. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. 1998;95(3):1142-7.

Fung ME, Thébaud BJPr. Stem cell–based therapy for neonatal lung disease: it is in the juice. 2013;75(1-1):2.

Baghaei K, Hashemi SM, Tokhanbigli S, Rad AA, Assadzadeh-Aghdaei H, Sharifian A, et al. Isolation, differentiation, and characterization of mesenchymal stem cells from human bone marrow. 2017;10(3):208.

Masur S, Dewal H, Dinh T, Erenburg I, Petridou SJPotNAoS. Myofibroblasts differentiate from fibroblasts when plated at low density. 1996;93(9):4219-23.

Petridou S, Maltseva O, Spanakis S, Masur SKJIo, science v. TGF-β receptor expression and smad2 localization are cell density dependent in fibroblasts. 2000;41(1):89-95.

Alberts B, Johnson A, Lewis J, Walter P, Raff M, Roberts K. Molecular Biology of the Cell 4th Edition: International Student Edition. Routledge; 2002.

ALTMAN G, HORAN R, Martin I, Farhadi J, STARK P, Volloch V, et al. Cell differentiation by mechanical stress. 2002;16(2):270-2.

Lee CH, Shah B, Moioli EK, Mao JJJTJoci. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. 2010;120(9):3340-9.

Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. 2010;19(6-7):667-79.

Melief SM, Zwaginga JJ, Fibbe WE, Roelofs HJSctm. Adipose tissue‐derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow‐derived counterparts. 2013;2(6):455-63.

P De Miguel M, Fuentes-Julian S, Blazquez-Martinez A, Y Pascual C, A Aller M, Arias J, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications. 2012;12(5):574-91.

Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic‐Canic MJWr, regeneration. Growth factors and cytokines in wound healing. 2008;16(5):585-601.

Nauta AJ, Fibbe WEJB. Immunomodulatory properties of mesenchymal stromal cells. 2007;110(10):3499-506.

Stagg J, Galipeau JJCmm. Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. 2013;13(5):856-67.

Gnecchi M, Danieli P, Malpasso G, Ciuffreda MC. Paracrine mechanisms of mesenchymal stem cells in tissue repair. Mesenchymal Stem Cells: Springer; 2016. p. 123-46.

Ohnishi S, Sumiyoshi H, Kitamura S, Nagaya NJFl. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. 2007;581(21):3961-6.

Menéndez-Menéndez Y, Otero-Hernández J, Vega JA, Pérez-Basterrechea M, Pérez-López S, Álvarez-Viejo M, et al. The role of bone marrow mononuclear cell-conditioned medium in the proliferation and migration of human dermal fibroblasts. 2017;22(1):29.




DOI: https://doi.org/10.22037/ghfbb.v0i0.1539